Capstone Investment Advisors’s Celgene Corp CELG Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q4 | – | Sell |
-1,342,761
| Closed | -$133M | – | 1518 |
|
|
2019
Q3 | $133M | Buy |
1,342,761
+30,378
| +2% | +$2.89M | 0.92% | 17 |
|
|
2019
Q2 | $121M | Buy |
1,312,383
+852,119
| +185% | +$80.9M | 0.88% | 15 |
|
|
2019
Q1 | $43.4M | Buy |
460,264
+435,594
| +1,766% | +$38.1M | 0.4% | 51 |
|
|
2018
Q4 | $1.58M | Buy |
24,670
+19,974
| +425% | +$1.47M | 0.02% | 498 |
|
|
2018
Q3 | $420K | Sell |
4,696
-27,534
| -85% | -$2.43M | ﹤0.01% | 841 |
|
|
2018
Q2 | $2.56M | Buy |
+32,230
| New | +$2.68M | 0.04% | 248 |
|
|
2017
Q3 | – | Sell |
-1,801
| Closed | -$245K | – | 850 |
|
|
2017
Q2 | $233K | Buy |
+1,801
| New | +$221K | 0.01% | 532 |
|
|
2017
Q1 | – | Sell |
-19,200
| Closed | -$2.3M | – | 1258 |
|
|
2016
Q4 | $2.22M | Sell |
19,200
-4,500
| -19% | -$501K | 0.07% | 260 |
|
|
2016
Q3 | $2.48M | Buy |
23,700
+8,200
| +53% | +$887K | 0.05% | 228 |
|
|
2016
Q2 | $1.53M | Sell |
15,500
-11,347
| -42% | -$1.17M | 0.03% | 280 |
|
|
2016
Q1 | $2.69M | Buy |
+26,847
| New | +$2.76M | 0.08% | 156 |
|
|
2015
Q4 | – | Sell |
-3,300
| Closed | -$356K | – | 626 |
|
|
2015
Q3 | $356K | Buy |
+3,300
| New | +$410K | 0.01% | 317 |
|
|
2014
Q1 | – | Sell |
-3,520
| Closed | -$297K | – | 607 |
|
|
2013
Q4 | $297K | Buy |
3,520
+2,600
| +283% | +$206K | ﹤0.01% | 451 |
|
|
2013
Q3 | $70K | Buy |
+920
| New | +$64.5K | ﹤0.01% | 502 |
|
Other funds holding CELG
Capstone Investment Advisors's CELG Position: Q4 2019 in Review
Capstone Investment Advisors sold out of Celgene Corp (CELG) in Q4 2019, closing a stake of 1,342,761 shares — an estimated $133M sold.
Capstone Investment Advisors first reported a position in CELG in Q3 2013 and held it in 14 quarters. The position peaked at $133M in Q3 2019. 3 funds tracked by Wall St. Rank hold CELG as of Q4 2019.
- Capstone Investment Advisors reported no remaining Celgene Corp position as of Q4 2019 after selling out during the quarter.
- Capstone Investment Advisors sold 1,342,761 Celgene Corp shares in Q4 2019, an estimated $133M.
- Capstone Investment Advisors first reported a position in Celgene Corp in Q3 2013 and held it in 14 quarters.
- Capstone Investment Advisors's Celgene Corp position peaked at $133M in Q3 2019.
- 3 funds tracked by Wall St. Rank held Celgene Corp as of Q4 2019.
Based on Capstone Investment Advisors's 13F filing for Q4 2019, filed 14 Feb 2020.